Oxford Performance Materials Inc. (OPM) announced that it has received a $ 150,000 grant from the National Institutes of Health (NIH) to develop 3D printed, antibiotic infused medical implants.
OPM will explore new approaches to improve the treatment of infections related to artificial hips, knees and other implanted devices through advanced applications of 3D printed PEKK (poly-ether-ketone-ketone). The NIH grant will support research developing new approaches for the delivery of antibiotics through OPM’s 3d printed PEKK implants.
Dr. Hacking, PhD, Chief Scientific Officer at OPM: “Device related infections are a burdensome clinical issue that results in prolonged patient suffering, increased mortality, and are expected to cost $12 billion per year by 2015. With this support from the NIH, we have the potential to rapidly advance treatment for bone and joint infections, reduce healthcare costs, reduce patient suffering and improve patient care.”